Nmc Pharma Synergy Profile
Key Indicators
- Authorised Capital ₹ 1.70 M
as on 18-07-2024
- Paid Up Capital ₹ 1.70 M
as on 18-07-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -1048.34%
(FY 2022)
- Ebitda -2054.06%
(FY 2022)
- Net Worth -4.28%
(FY 2022)
- Total Assets -3.62%
(FY 2022)
About Nmc Pharma Synergy
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.70 M and a paid-up capital of Rs 1.70 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Bhasin, Geeta Bhasin, and Sonali Kumar serve as directors at the Company.
- CIN/LLPIN
U51397DL2004PTC126570
- Company No.
126570
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nmc Pharma Synergy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Bhasin  | Director | 06-Dec-2005 | Current |
| Geeta Bhasin | Director | 06-Dec-2005 | Current |
| Sonali Kumar | Director | 30-Jun-2016 | Current |
Financial Performance and Corporate Structure Insights of Nmc Pharma Synergy.
Nmc Pharma Synergy Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1048.34% decrease in profit. The company's net worth dipped by a decrease of 4.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nmc Pharma Synergy?
In 2021, Nmc Pharma Synergy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
A.F. Farms And Horticulture Services Private LimitedActive 26 years 7 monthsAtul Bhasin is a mutual person
- Utopia Engineering Private LimitedActive 17 years 11 months
Atul Bhasin and Geeta Bhasin are mutual person
- Sagavi Promoters And Developers India Private LimitedActive 28 years 8 months
Atul Bhasin, Geeta Bhasin and 1 more are mutual person
- Alaknanda Properties Private LimitedActive 23 years 1 month
Atul Bhasin and Geeta Bhasin are mutual person
- Avr Goa Promoters Private LimitedActive 19 years 1 month
Atul Bhasin, Geeta Bhasin and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nmc Pharma Synergy?
Unlock and access historical data on people associated with Nmc Pharma Synergy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nmc Pharma Synergy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nmc Pharma Synergy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
